financetom
Business
financetom
/
Business
/
Market Chatter: Former BoC Governor Mark Carney Warns of "Slower and Shallower" Rate Cuts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Former BoC Governor Mark Carney Warns of "Slower and Shallower" Rate Cuts
Apr 9, 2024 11:51 AM

02:43 PM EDT, 04/09/2024 (MT Newswires) -- Former Bank of Canada and Bank of England governor Mark Carney warned that central banks may cut interest rates more slowly and by less than many expect as monetary policy adjusts to a new era defined by structurally higher inflation, The Globe and Mail newspaper is reporting Tuesday.

Speaking at an event in Ottawa on Monday evening, Carney said central banks are likely to start lowering interest rates this year as inflation continues to decline. "But expect those cuts to be slower and shallower," he said. "And what's more relevant, for most companies and individuals and households, is that in the medium-term, rates are going to be higher [than before], and are going to be higher because of structural things, and you better be prepared for that."

The report noted this echoes remarks made by current Bank of Canada Governor Tiff Macklem after the last rate decision in March. When asked about the likely trajectory of rate cuts, Macklem said that "it's very safe to say we're not going to be lowering rates at the pace we raised them."

The Bank of Canada's next rate decision is on Wednesday. The report noted most analysts expect the central bank to keep its benchmark rate steady at 5% for the sixth consecutive time, although they're watching for a shift in tone that could set the stage for rate cuts over the summer.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kratos Receives $79.9 Million US Air Force Contract
Kratos Receives $79.9 Million US Air Force Contract
Sep 17, 2024
08:32 AM EDT, 09/17/2024 (MT Newswires) -- Kratos Defense & Security Solutions (KTOS) said Tuesday it has received a $79.9 million contract to deliver 60 aircraft for the BQM-167A aerial target drone system, including upgrades and mission kits, to the US Air Force. The company said that under the five-year agreement, it will provide Gas, Aero, Payload and Power enhancements...
Intuit releases enterprise suite of financial products to tap new customers
Intuit releases enterprise suite of financial products to tap new customers
Sep 17, 2024
Sept 17 (Reuters) - TurboTax maker Intuit said on Tuesday it has released a new customizable enterprise suite of its financial products in the United States to capture new customers looking for an all-in-one solution for managing their financial needs. Enterprise customers are increasingly looking to invest in AI-powered platforms that integrate various products of their choice into a single...
Douglas Dynamics Names Mark Van Genderen as COO
Douglas Dynamics Names Mark Van Genderen as COO
Sep 17, 2024
08:34 AM EDT, 09/17/2024 (MT Newswires) -- Douglas Dynamics ( PLOW ) said Tuesday that it promoted Mark Van Genderen to serve as chief operating officer of the company effective immediately. Genderen will also serve as president of the company's Work Truck Attachments unit with immediate effect. The company said Genderen, who joined Douglas Dynamics ( PLOW ) in 2020,...
BioCryst Pharmaceuticals Completes Negotiations with Canadian Pricing Organization for Orladeyo
BioCryst Pharmaceuticals Completes Negotiations with Canadian Pricing Organization for Orladeyo
Sep 17, 2024
08:31 AM EDT, 09/17/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Tuesday that it has completed price negotiations with the pan-Canadian Pharmaceutical Alliance for Orladeyo, BioCryst's treatment for hereditary angioedema. The negotiation process concluded on Thursday last week, according to the pCPA's website. BioCryst said it now expects to partner with the individual public drug plans of provinces...
Copyright 2023-2025 - www.financetom.com All Rights Reserved